I really don't want to be a doctor

Chapter 449 Monoclonal Antibody Group
As soon as the words fell, everyone in the laboratory began to discuss.

They are all members of the "Immune Checkpoint Inhibitors" project team, so they are naturally familiar with this project and know the development history at home and abroad.

Large pharmaceutical companies in Europe and the United States, such as AstraZeneca, Bayer, and Pfizer, have spent more than five to ten years on immune checkpoint inhibitor projects.

Since the establishment of Shenzhou Laboratories, it has only been one year, and the time spent on research and development of immune checkpoint inhibitors will not exceed one year!
One year!

Just this year, it surpassed the giant pharmaceutical companies in Europe and the United States.

The huge potential of Shenzhou Laboratory can be seen in general!
Everyone quickly figured this out.

Jing Xiaoran looked around the laboratory and said loudly: "It took only one year for our Shenzhou laboratory to complete the decades-long research and development process of AstraZeneca, so what else is impossible?"

Hong Sheng's eyes lit up, he knew very well the development process of the entire Shenzhou Laboratory.

From scratch, from a team of only three people to dozens of people, the development of Shenzhou Laboratory can be said to be extremely fast, but at the same time the foundation is also very solid.

However, at this time, many researchers are still very pessimistic, because the most important thing in scientific research is the result, and they don't care about the process.

The result now is that AstraZeneca has become the first!

"Mr. Jing, but now that AstraZeneca has completed the research and development first, what's the point of our remaining work?" A relatively old employee stood up and said.

Jing Xiaoran knew him, his name was Cheng Bo, and he was a graduate student who graduated from a 211 college in central China.

Jing Xiaoran smiled when he heard the words, and instead of answering Cheng Bo, he asked everyone in the laboratory: "Do you all have the same views as Cheng Bo?"

In the laboratory, there was no sound.

Although everyone didn't speak, Jing Xiaoran could feel that they had similar thoughts with Cheng Bo.

Jing Xiaoran suddenly took out a USB flash drive from his pocket, plugged it into the computer in the conference hall, found one of the files, and said slowly: "Then let me tell you, next, the laboratory will set up a brand new project... the same is in the field of oncology”

Zhu Xianqing at the side looked at Jing Xiaoran suspiciously, he had never heard of such a thing?

Why did a brand new scientific research project suddenly appear? Looking at the data in Jing Xiaoran's USB flash drive, it should have been thought of for a long time, and it doesn't seem like it was conceived recently.

Just give up immune checkpoint inhibitors?
This is absolutely impossible, Zhu Xianqing knew how much Jing Xiaoran had spent on this medicine.

Zhu Xianqing sighed, wanting to see what kind of medicine Jing Xiaoran was selling in the gourd!

"This brand new drug program is about the monoclonal antibody Naxitamab, an IgG2 humanized monoclonal antibody targeting GD1, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), for the treatment of 1-year-old The above patients with relapsed/refractory high-risk neuroblastoma..."

At first glance, the project that Jing Xiaoran mentioned is really true.

"Our Shenzhou Laboratory is leading the world in this drug project!" Jing Xiaoran said, "There is no other company competing with us at the same time."

Speaking of this, Jing Xiaoran paused for a moment, looked at Cheng Bo in the audience, and then continued: "I decided to set up the third project of Shenzhou Laboratory - the monoclonal antibody project team starting tomorrow! Based on the current Due to the situation, some people need to be assigned from the immune checkpoint inhibitor project, and those who want to leave the immune checkpoint inhibitor project team can apply to join the monoclonal antibody project team now."

Everyone present was shocked, there is such a good thing?
It is of no benefit to them to be clinging to a drug with no future. If the drug cannot be marketed and the patent is not sold, their salary performance share will be much less.

Now there is actually a second choice, and it is the only laboratory in the world that develops this drug.

More importantly, everyone knows more or less about the feasibility of monoclonal antibodies and the feasibility of this project!
Everyone here is a member of the immune checkpoint inhibitor project team, and everyone's heart became active when they heard Jing Xiaoran's words.

Changing groups means that the future is still bright.

Otherwise, if we die on the immune checkpoint inhibitor project team, we really can't see the slightest hope.

But for a while, no one took the initiative to take the lead, and everyone was still watching.

At this time, Jing Xiaoran fueled the fire again.

"The number of places in this project team is limited. You can seriously consider it. If it is full, you will have to stay in the immune checkpoint inhibitor project team."

Under the stage, Cheng Bo's eyes flickered, he stood up and said, "Mr. Jing, are there no other project teams?"

"It's gone." Jing Xiaoran said.

"Then I will apply to be the first to join the monoclonal project team." Cheng Bo gritted his teeth.

"Really?" Jing Xiaoran smiled, "Think about it clearly, joining the monoclonal antibody group means that you will automatically withdraw from the immune checkpoint inhibitor project, and you will never be able to come back."

"Yeah! Think it through." Cheng Bo nodded, "I'm applying to enter the monoclonal antibody group."

"That's good." Jing Xiaoran smiled and wrote down Cheng Bo's name on the screen, "Is there anyone else?"

After Cheng Bo took the lead, three more researchers chose to join the monoclonal antibody group.

In the audience, Ah Wei was hesitating. He is now in the immune checkpoint inhibitor project team, and he can only be regarded as an "experimental dog", and he has no access to the core experimental part at all.

If you can add monoclonal antibodies earlier, you may get a few SCI papers with the second author and the third author!
"Hong Sheng, do you think I should go to the monoclonal antibody group?" Ah Wei looked at Hong Sheng who was on the side.

Hong Sheng said very clearly: "Don't go! Just stay in the immune checkpoint inhibitor project team."

"Ah? Why?" Ah Wei wondered, "Since Mr. Jing proposed this project team on his own initiative, I definitely hope that everyone can participate."

Hong Sheng shook his head and said, "No, the reason why the squad leader suddenly proposed this project team is just for screening."

"filter?"

"Yes, select the most suitable person for the immune checkpoint inhibitor project team!" Hong Sheng said.

Awei was still in the fog, wondering: "Then what's the point of him doing this? Isn't the immune checkpoint inhibitor project team almost finished? Now is the time to transfer resources and carry out research and development of other projects."

(End of this chapter)